Evaluation of Safety of Filler Injection in Subcutaneous Tissues (NCT06322043) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Evaluation of Safety of Filler Injection in Subcutaneous Tissues
Switzerland18 participantsStarted 2024-03-26
Plain-language summary
Adipearl is an injectable filler intended to be injected subcutaneously.
Who can participate
Age range22 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subject having given freely and expressly informed consent;
* Subject deemed by the Investigator to be medically fit for injection of the product;
* Female or male subjects aged 22 to 65 years (inclusive);
Exclusion Criteria:
* Pregnant or nursing woman or planning a pregnancy during the study.
* Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship.
* Subject participating to another research study.
* Subject with the presence of any condition, which in the opinion of the Principal Investigator, that makes her/him unable to complete the study per protocol.